All Health Stories

  1. FDA Approves First Non-Antipsychotic Drug for Agitation in Alzheimer’s Patients

    FDA Approves First Non-Antipsychotic Drug for Agitation in Alzheimer’s Patients

    The FDA has expanded the use of Auvelity, originally for depression, to treat agitation in Alzheimer's disease, offering a new option for patients and caregivers.

    last mo. 2 min read
  2. How Mental Health Dampens Midlife Sexual Desire for Women

    How Mental Health Dampens Midlife Sexual Desire for Women

    Expert analysis on how anxiety, depression, ADHD, and trauma impact libido, plus practical steps to reclaim desire.

    last mo. 1 min read
  3. Women's Hormonal Condition PCOS Renamed to PMOS in Global Push for Accuracy

    Women's Hormonal Condition PCOS Renamed to PMOS in Global Push for Accuracy

    Experts rename PCOS to PMOS to reflect its metabolic and hormonal complexity, aiming to reduce misdiagnosis and stigma.

    last mo. 1 min read
  4. PCOS Renamed to PMOS After Global Consensus Effort

    PCOS Renamed to PMOS After Global Consensus Effort

    The hormonal disorder affecting 1 in 8 women is now called Polyendocrine Metabolic Ovarian Syndrome, reflecting its true nature beyond ovarian cysts.

    last mo. 1 min read
  5. Major Cochrane Review Questions Effectiveness of Alzheimer's Drugs

    Major Cochrane Review Questions Effectiveness of Alzheimer's Drugs

    A Cochrane review finds amyloid-targeting drugs offer little benefit, sparking debate among experts and drugmakers.

    last mo. 1 min read
  6. WHO Reports No Signs of Wider Hantavirus Outbreak Despite Rising Cases

    WHO Reports No Signs of Wider Hantavirus Outbreak Despite Rising Cases

    WHO says hantavirus risk remains low globally after MV Hondius cruise ship outbreak, with 11 cases and 3 deaths confirmed.

    last mo. 1 min read
  7. Isomorphic Labs Raises $2.1B to Scale AI Drug Discovery

    Isomorphic Labs Raises $2.1B to Scale AI Drug Discovery

    Google-backed Isomorphic Labs secures $2.1 billion in Series C funding to scale its AI-powered drug design engine and accelerate clinical trials.

    last mo. 1 min read
  8. After 14 Years, PCOS Is Renamed PMOS in Global Consensus

    After 14 Years, PCOS Is Renamed PMOS in Global Consensus

    Polycystic Ovary Syndrome has been renamed Polyendocrine Metabolic Ovarian Syndrome in a landmark global effort led by Monash University to improve diagnosis and care.

    last mo. 1 min read